- Additionally, tirzepatide was associated with 1.3-, 1.6-, 1.8-, and 2.0-fold higher likelihoods of achieving 10%, 15%, 20%, and 25% weight reduction, respectively, compared to semaglutide
GLP-1 is not recommended for type 1 diabetes
Similar content being viewed by others Introduction All eukaryotic cells possess a highly efficient endomembrane system that ensures the precise transport of biomacromolecules, such as proteins, to their designated locations, allowing them to carry out their functions effectively 1
They include semaglutide (Ozempic, Rybelsus, Wegovy), tirzepatide (Mounjaro, Zepbound), and dulaglutide (Trulicity), among others